News
UPMC has created a blueprint for treating patients experiencing gruesome side effects from drugs laced with xylazine.
17h
MedPage Today on MSNNovel Smoking Cessation Drug Clears Last Hurdle Before FDAThe prior ORCA-V1 trial showed efficacy of cytisinicline for vapers looking to quit. For smokers, the ORCA-2 trial showed ...
4h
Stockhead on MSNLunch Wrap: ASX lights up as risk returns; Paladin rockets 25pc but gold sees heavy profit-takingThe ASX lit up on Wall Street buzz and hopes of a China trade thaw, sending gold tumbling as risk came back on the menu.
The Inquirer’s analysis found that, between 2020 and 2023, about 450 people hospitalized in Philadelphia with an opioid use ...
Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results